节点文献

凋亡及凋亡相关蛋白Bax在局部晚期宫颈癌同步放化疗中的表达

Apoptosis and Expression of Apoptosis-associated Bax Protein during Synchronal Radiochemotherapy of Locally Advanced Uterine Cervix Cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 甘浪舸蒿艳蓉阮林李祥攀

【Author】 Gan Langge Hao Yanrong Ruan Lin et al Departmet of Radiation Oncology, the First Affiliate Hospital of Guangxi Medical University, Nanning

【机构】 广西医科大学第一附属医院放疗科广西医科大学第一附属医院放疗科 南宁市530021南宁市530021

【摘要】 目的:研究局部晚期宫颈鳞癌细胞对同步放化疗应答的分子机制,探讨凋亡及Bax、Bcl-2的表达。方法:49例局部晚期宫颈鳞癌患者随机分为两组:单纯放疗(RT)组25例接受盆腔外照射和后装治疗;同步放化疗(CRT)组24例除接受放疗外,还接受3个周期的化疗(DDP+5-FU)。在治疗前和治疗过程中(RT组:放疗10Gy后;CRT组:放疗10Gy+(DDP+5-FU)×1个周期)分别活检留取标本,用TUNEL法及免疫组化检测凋亡及Bax、Bcl-2的表达。结果:RT组和CRT组完全缓解率分别为52.0%和79.2.0%(P=0.044)。在治疗前和治疗过程中,RT组和CRT组凋亡阳性率均增加,分别由24%上升到60.0%(P=0.01)和20.8%增加到87.5%(P=0.000),差异显著;治疗中CRT组较RT组增加更加明显(P=0.03)。Bax的表达亦增加,分别由24.0%上升到52.0%(P=0.021)和25.0%增加到79.2%(P=0.000),差异显著;CRT组较RT组增加的更显著(P=0.044)。两组在治疗中,凋亡的阳性率和Bax的阳性表达密切相关,CRT组较RT组相关性更强(P=0.015,r=0.827:P=0.027,r=0.523),但两组Bcl-2的表达无变化(P>0.05)。结论:局部晚期宫颈鳞癌,CRT比RT有更好的缓解率,其机制可能是化疗和放疗有协同作用,通过上调Bax通路诱导了肿瘤细胞的凋亡。

【Abstract】 Objective: To investigate the molecular mechanism of cell death after radiotherapy or radiochemotherapy of locally advanced uterine cervix cancer (UCC) and to discuss the apoptosis and expression of Bax and Bcl-2 protein. Methods: Forty-nine patients with UCC were randomized into two groups: the radiotherapy (RT) group with 25 patients who were given simple external irradiation of the pelvic cavity and after-loading therapy and, the synchronal radiochemotherapy (CRT) group with 24 patients who were given 3 cycles of chemotherapy (DDP+5-FU) besides the RT. Biopsy of the UCC was conducted before and during the treatment(group RT: after 10 Gy radiotherapy; group CRT: 10 Gy radiotherapy+{DDP+5-FU}×1 cycle). The samples obtained in the treatment were employed to determine apoptosis and the expression of Bax and Bcl-2 protein using TUNEL and immunohistochemical methods. Results: A complete response achieved 52% of the RT group and 79.2%ofCRT group, respectively (P=0.044). Before and during the treatment, the positive rates of apoptosis were increased, ranging from 24%to 60%(P=0.01) in the RT group and from 20.8% to 87.5% (P=0.000) in the CRT group, respectively. There was a significant difference between the two groups, especially during the treatment(P= 0.03). The positive rate of Bax protein was increased, too. They were 24% and 25%, before treatment, and 52% and 79.2%, after treatment, in the RT and CRT group, respectively, with a significant difference(P=0.021 and P=0.000). There was a significant correlation between the expression of Bax and apoptosis, after treatment in both groups(P=0.015,r=0.827 vs P=0.027,r=0.523). However, there was no change in the expression of Bcl-2 in the two groups (P>0.05). Conclusions: There is a better remission rate in CRT of the UCC compared to the RT. An additive or synergistic anti-cancer effect might be the mechanism of CRT, which is realized by up-regulating Bax pathway for induction of tumor-cell apoptosis.

【基金】 广西壮族自治区卫生厅科研基金资助(编号:Z2005023)
  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,2007年05期
  • 【分类号】R737.33
  • 【被引频次】2
  • 【下载频次】148
节点文献中: 

本文链接的文献网络图示:

本文的引文网络